The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Burke Steven Keith since 2017.
This trader's CIK number is 1619834.
At the time of last reporting, Burke Steven Keith was the SVP, Chief Medical Officer of Akebia Therapeutics, Inc.. (stock ticker symbol AKBA).
Also see all insider trading activities at Akebia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | PRTO | 12,000 | $22,560 | 0 | $0 | 70,221 | $128,153 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AKBA | 0 | $0 | 57,650 | $119,135 | 0 | $0 |
| 2023 | AKBA | 0 | $0 | 66,847 | $95,935 | 0 | $0 |
| 2023 | AKBA | 0 | $0 | 85,229 | $86,417 | 0 | $0 |
| 2022 | AKBA | 0 | $0 | 15,056 | $32,567 | 0 | $0 |
| 2021 | AKBA | 0 | $0 | 9,681 | $32,289 | 0 | $0 |
| 2019 | AKBA | 27,000 | $96,660 | 0 | $0 | 0 | $0 |
1. Protara Therapeutics, Inc. (PRTO)
2. Akebia Therapeutics, Inc. (AKBA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-15 | PRTO | Buy | 12,000 | 1.88 | 22,560 |
| 2017-03-10 | PRTO | Option Ex | 70,221 | 1.82 | 128,153 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | AKBA | Sale | 7,144 | 1.83 | 13,073 |
| 2025-02-03 | AKBA | Sale | 50,506 | 2.10 | 106,062 |
| 2023-08-25 | AKBA | Sale | 27,000 | 1.15 | 31,049 |
| 2024-02-29 | AKBA | Sale | 7,169 | 1.58 | 11,327 |
| 2024-02-27 | AKBA | Sale | 8,367 | 1.52 | 12,717 |
| 2024-02-01 | AKBA | Sale | 24,311 | 1.68 | 40,842 |
| 2023-05-16 | AKBA | Sale | 63,567 | 1.07 | 67,889 |
| 2023-03-01 | AKBA | Sale | 14,123 | .88 | 12,399 |
| 2023-02-27 | AKBA | Sale | 7,539 | .81 | 6,129 |
| 2022-02-28 | AKBA | Sale | 7,400 | 2.15 | 15,946 |
| 2022-03-01 | AKBA | Sale | 7,656 | 2.17 | 16,621 |
| 2021-08-31 | AKBA | Sale | 1,042 | 2.83 | 2,948 |
| 2021-04-01 | AKBA | Sale | 1,081 | 3.40 | 3,675 |
| 2021-03-01 | AKBA | Sale | 7,558 | 3.40 | 25,666 |
| 2019-11-20 | AKBA | Buy | 27,000 | 3.58 | 96,660 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burke Steven Keith (SVP, Chief Medical Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.